Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million

edition.cnn.com/2025/05/19/business/regeneron-23-and-me

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday.
Regeneron said it will comply with 23andMe’s privacy policies and applicable laws with respect to the use of customer data and that it is…

This story appeared on edition.cnn.com, 2025-05-19 00:00:00.
The Entire Business World on a Single Page. Free to Use →